IRLAB Therapeutics: IRLAB has Received a Waiver from the EMA Regarding Pediatric Studies with Mesdopetam in Parkinson's Disease
GOTHENBURG, SE / ACCESS Newswire / January 23, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 23, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company dis ...